Bright Minds Biosciences (DRUG) Other Non Operating Income (2020 - 2026)

Bright Minds Biosciences (DRUG) has 7 years of Other Non Operating Income data on file, last reported at -$1.6 million in Q1 2026.

• Quarterly Other Non Operating Income fell 2208.38% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $737804.7 (up 165.39% YoY) and the FY2025 annual result came in at $137165.4, up 2109.4% from the prior year.
• Other Non Operating Income retreated to -$1.6 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.9 million in Q2 2025 to a low of -$1.6 million in Q1 2026.
• A 5-year average of -$22005.2 and a median of $7523.4 in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2024 — Other Non Operating Income slumped 11147.86% — and 2025, when it surged 13247.08%.
• Tracing DRUG's Other Non Operating Income over 5 years: stood at $27356.7 in 2022, then slumped by 60.45% to $10820.4 in 2023, then tumbled by 11147.86% to -$1.2 million in 2024, then jumped by 188.75% to $1.1 million in 2025, then tumbled by 249.14% to -$1.6 million in 2026.
• The last three Other Non Operating Income figures came in at -$1.6 million (Q1 2026), $1.1 million (Q4 2025), and -$675577.3 (Q3 2025), per Business Quant data.